Maybe as a p4 trial they could perform a small scale fresh ERT head 2 head? I think that would be super compelling for prescribers!
I also still have wondered about the once a month dosing protocol. Like every article says "may be able to do that" but what does the data say for the once monthly dosing? Was the drug effective enough? Is there NDA/EMA submissions gunning for a once a month dose protocol in labeling discussions? My guess is not as they wanna stay conservative for initial approval then work towards getting additional labelings down the road for once a month... guess time will tell but if the once a month dosing comes to fruition thats a huge advantage too.
$PLX has been on my radar for a while. Ever since Moon Kil Woong first wrote abuot it. I believe the stock shows tremendous promise and is quite affordable.
Protalix BioTherapeutics Well Placed to Advance in 2023
Bullish on $PLX.
Protalix BioTherapeutics Well Placed to Advance in 2023
Maybe as a p4 trial they could perform a small scale fresh ERT head 2 head? I think that would be super compelling for prescribers!
I also still have wondered about the once a month dosing protocol. Like every article says "may be able to do that" but what does the data say for the once monthly dosing? Was the drug effective enough? Is there NDA/EMA submissions gunning for a once a month dose protocol in labeling discussions? My guess is not as they wanna stay conservative for initial approval then work towards getting additional labelings down the road for once a month... guess time will tell but if the once a month dosing comes to fruition thats a huge advantage too.
I'm bullish on $PLX.
Protalix BioTherapeutics Well Placed to Advance in 2023
I read your last article on $PLX as well which was equally impressive. Sounds like the company has a promising 2023 to look forward too!
Protalix PRX-102: Likely Approval Could Be A Game Changer
Sounds very promising. Just picked up some $PLX.
Why Protalix Is Back On The Radar
Bullish on $PLX.
Why Protalix Is Back On The Radar
$PLX has been on my radar for a while. Ever since Moon Kil Woong first wrote abuot it. I believe the stock shows tremendous promise and is quite affordable.
Protalix BioTherapeutics: Management Sounds Confident Despite CRL
Seems like the CLR was completely unfair since it was the FDA that was unable to do the inspection. That should not reflect negatively on $PLX at all.
Protalix BioTherapeutics: Management Sounds Confident Despite CRL
I'm bullish on $PLX.
Protalix BioTherapeutics: Management Sounds Confident Despite CRL
Good read, thanks. Moon Kil Woong, you've often covered $PLX. What's your take?
PLX Upcoming Volatility Creates Opportunity
Had our eyes on $PLX for a while now. I think big things are coming for this company.